| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |